Richard Lehman, MD
Orthopedic Surgery · Saint Louis, MONPI 1851392377
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Elite Orthopedics, LLC at 55.3% of the total. Reporting peaked in 2019 at $2,065 and has fallen 99.4% since, to $13 in 2023.
Across 114 payments — averaging $45.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$3K
- Arthrex$737
- Zyla Life Sciences, Inc.$322
- Amgen$305
- Pacira Therapeutics, Inc.$287
- Baxter Healthcare$151
- plus $493 from 12 others
What the payments were for
- Travel & lodging$4018%
- Food & beverage$1,71933%
- Education$3,01159%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 6 | $2,836 |
| Arthrex | 3 | $737 |
| Zyla Life Sciences, Inc. | 32 | $322 |
| Amgen | 25 | $305 |
| Pacira Therapeutics, Inc. | 17 | $287 |
| Baxter Healthcare | 3 | $151 |
| Ferring Pharmaceuticals Inc. | 8 | $110 |
| Assertio Therapeutics, Inc. | 6 | $83 |
| Smith+Nephew | 2 | $73 |
| Bioventus LLC | 2 | $53 |
| Stryker | 1 | $49 |
| Zimmer Biomet | 3 | $38 |
| Johnson & Johnson | 1 | $20 |
| Acerus Pharmaceuticals Corporation | 1 | $18 |
| Iroko Pharmaceuticals, LLC | 1 | $14 |
| Vericel Corporation | 1 | $13 |
| Sentynl Therapeutics, Inc. | 1 | $12 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOSEAL$110
How this compares
Too few orthopedic surgery providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 30 | $1,096 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $271 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $243 |
| Cephalexin | 14 | $45 |
| Prednisone | 20 | $23 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Saint Louis
- Leo WhitesideSaint Louis$500K
- Zachary BurnettSaint Louis$56K
- Daniel MartinSaint Louis$1K
- Alan MorrisSaint Louis$0
- Robert MarkensonSaint Louis$0
- John KrauseChesterfield$7K
- Steven SmithNorth Kansas City$4K
- Mitchell RotmanChesterfield$2K
- James ReardonNorth Kansas City$1K
- Hee LeeColumbia$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.